PRODUCTION OF 1,25-DIHYDROXYVITAMIN-D-3 BY PERFUSED PIG SKIN

被引:21
作者
BIKLE, DD
HALLORAN, BP
RIVIERE, JE
机构
[1] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
[2] N CAROLINA STATE UNIV,COLL VET MED,CTR CUTANEOUS PHARMACOL TOXICOL,RALEIGH,NC 27606
关键词
1,25(OH)D-2(3); 24,24(OH)D-2(3); PIG; SKIN; KERATINOCYTES; PERFUSION;
D O I
10.1111/1523-1747.ep12378190
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Keratinocytes produce large amounts of 1,25 dihydroxyvitamin D-3 (1,25(OH)(2)D-3) in vitro. 1,25(OH)(2)D-3 is detectable in anephric humans and pigs and can be increased to near-normal levels by vitamin D or 250HD, indicating an extrarenal source. To determine whether the skin is one of these extrarenal sources, we perfused isolated flaps of porcine skin for 8 h with 250HD(3) in serum-free medium at 1 ml/min, collecting the venous effluent as 15-min samples. The samples were extracted and the vitamin D metabolites purified by high-performance liquid chromatography and assayed by competitive protein-binding techniques. Production of 1,25(OH)(2)D-3 continued for the duration of the perfusion, tending to increase in the last 2 hours. The amount of 1,25(OH)(2)D-3 produced varied both with time in the same pig skin and between pig skins; maximum production of 1,25(OH)(2)D-3 in these experiments was 8 pg/min. 24,25(OH)(2)D-3 production was higher than 1,25(OH)(2)D-3 production, reaching a maximum rate of 180 pg/min. Considering that the production rate of 1,25(OH)(2)D-3 in humans is 1.25 ng/min and that a 48-cm(2) skin flap represents 1/350 the surface area of a human, and assuming that human and pig skin make 1,25(OH)(2)D-3 at comparable rates, one can determine that the skin has the potential to maintain near-normal levels of 1,25(OH)(2)D-3 in the absence of kidneys when provided with adequate substrate.
引用
收藏
页码:796 / 798
页数:3
相关论文
共 22 条
  • [1] HYPERCALCEMIA IN AN ANEPHRIC PATIENT WITH SARCOIDOSIS - EVIDENCE FOR EXTRA-RENAL GENERATION OF 1,25-DIHYDROXYVITAMIN-D
    BARBOUR, GL
    COBURN, JW
    SLATOPOLSKY, E
    NORMAN, AW
    HORST, RL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (08) : 440 - 443
  • [2] NEONATAL HUMAN FORESKIN KERATINOCYTES PRODUCE 1,25-DIHYDROXYVITAMIN-D3
    BIKLE, DD
    NEMANIC, MK
    WHITNEY, JO
    ELIAS, PW
    [J]. BIOCHEMISTRY, 1986, 25 (07) : 1545 - 1548
  • [3] 1,25-DIHYDROXYVITAMIN-D3 PRODUCTION BY HUMAN KERATINOCYTES - KINETICS AND REGULATION
    BIKLE, DD
    NEMANIC, MK
    GEE, E
    ELIAS, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (02) : 557 - 566
  • [4] VITAMIN-D, CALCIUM, AND EPIDERMAL DIFFERENTIATION
    BIKLE, DD
    PILLAI, S
    [J]. ENDOCRINE REVIEWS, 1993, 14 (01) : 3 - 19
  • [5] BIKLE DD, 1988, ENDOCRINOLOGY, V124, P649
  • [6] BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
  • [7] CHRONIC 1,25-DIHYDROXYVITAMIN-D3 ADMINISTRATION IN THE RAT REDUCES THE SERUM CONCENTRATION OF 25-HYDROXYVITAMIN-D BY INCREASING METABOLIC-CLEARANCE RATE
    HALLORAN, BP
    BIKLE, DD
    LEVENS, MJ
    CASTRO, ME
    GLOBUS, RK
    HOLTON, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (03) : 622 - 628
  • [8] PRODUCTION AND METABOLIC-CLEARANCE OF 1,25-DIHYDROXYVITAMIN-D IN MEN - EFFECT OF ADVANCING AGE
    HALLORAN, BP
    PORTALE, AA
    LONERGAN, ET
    MORRIS, RC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (02) : 318 - 323
  • [9] HENRY HL, 1979, VITAMIN D BASIC RES, P467
  • [10] HOLICK MF, 1981, J INVEST DERMATOL, V76, P51